Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-18

Clinical Trial Update: Vigor and the LDR in Parkinson Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Vigor and the LDR in Parkinson disease has completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigor (Vigor)

Snippet

Sponsor: University of Michigan | Conditions: Parkinson Disease | Phase 4 | Status: COMPLETED | Results posted: 2025-07-18